Cargando…
Correction: Postoperative intravenous parecoxib sodium followed by oral celecoxib post total knee arthroplasty in osteoarthritis patients (PIPFORCE): a multicentre, double-blind, randomised, placebo-controlled trial
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064064/ https://www.ncbi.nlm.nih.gov/pubmed/32152176 http://dx.doi.org/10.1136/bmjopen-2019-030501corr1 |
Ejemplares similares
-
Postoperative intravenous parecoxib sodium followed by oral celecoxib post total knee arthroplasty in osteoarthritis patients (PIPFORCE): a multicentre, double-blind, randomised, placebo-controlled trial
por: Zhuang, Qianyu, et al.
Publicado: (2020) -
Efficacy and safety of Postoperative Intravenous Parecoxib sodium Followed by ORal CElecoxib (PIPFORCE) post-total knee arthroplasty in patients with osteoarthritis: a study protocol for a multicentre, double-blind, parallel-group trial
por: Zhuang, Qianyu, et al.
Publicado: (2016) -
The effect of parecoxib sodium on postoperative delirium in elderly patients with hip arthroplasty
por: Wang, Jin-Huo, et al.
Publicado: (2023) -
Analgesic Effects of Intra-Articular Bupivacaine/Intravenous Parecoxib Combination Therapy versus Intravenous Parecoxib Monotherapy in Patients Receiving Total Knee Arthroplasty: A Randomized, Double-Blind Trial
por: Shen, Shih-Jyun, et al.
Publicado: (2015) -
Comparison of intra-articular injection of parecoxib vs oral administration of celecoxib for the clinical efficacy in the treatment of early knee osteoarthritis
por: Lu, Lu, et al.
Publicado: (2019)